MetLife Investment Management, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in CRNX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,973,120
-$345,907 QoQ
Shares Held
54,326
+9.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. CRNX ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
708,527 | $13,858,788 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,973,120 | 54,326 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,319,027 | 49,818 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,224,693 | 53,414 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,536,186 | 53,414 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,791,505 | 53,414 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,710,912 | 53,020 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,296,178 | 44,935 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,012,638 | 44,935 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,592,429 | 34,019 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,210,396 | 34,019 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,011,725 | 34,019 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $505,406 | 28,047 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $450,434 | 28,047 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $513,260 | 28,047 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $535,288 | 27,255 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $474,027 | 25,417 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $557,903 | 25,417 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $464,617 | 16,354 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $245,190 | 11,648 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $219,564 | 11,648 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $177,981 | 11,648 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $179,648 | 12,732 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $199,510 | 12,732 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $223,064 | 12,732 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $85,774 | 5,835 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||